Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (20)

2021

  1. Genetic underpinnings of sociability in the general population

    Neuropsychopharmacology, Vol. 46, Núm. 9, pp. 1627-1634

2019

  1. A quantitative approach to neuropsychiatry: The why and the how

    Neuroscience and Biobehavioral Reviews, Vol. 97, pp. 3-9

2014

  1. Common variant at 16p11.2 conferring risk of psychosis

    Molecular Psychiatry, Vol. 19, Núm. 1, pp. 108-114

  2. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: A review of the literature

    Primary Care Companion to the Journal of Clinical Psychiatry, Vol. 16, Núm. 3

2013

  1. Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia

    Schizophrenia Research, Vol. 150, Núm. 2-3, pp. 328-333

1997

  1. Olanzapine in treatment-refractory schizophrenia: Results of an open- label study

    Journal of Clinical Psychiatry, Vol. 58, Núm. 11, pp. 479-483